Kodiak Sciences (KOD) Amortization of Deferred Charges (2017 - 2022)
Kodiak Sciences' (KOD) quarterly Amortization of Deferred Charges came in at $2.2 million in Q1 2026, up 4.99% YoY from $2.1 million in Q1 2025, and up 13.19% on a QoQ basis from $2.0 million in Q4 2025.
Analysis
Kodiak Sciences (KOD) Amortization of Deferred Charges (2017 - 2022) Analysis & Trends
Kodiak Sciences (KOD) has 9 years of Amortization of Deferred Charges data on file, last reported at $2.2 million in Q1 2026.
- Quarterly Amortization of Deferred Charges rose 4.99% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.1 million (down 0.98% YoY) and the FY2025 annual result came in at $8.0 million, changed 0.05% from the prior year.
- Amortization of Deferred Charges improved to $2.2 million in Q1 2026, from $2.0 million in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $2.2 million in Q1 2026 to a low of $1.7 million in Q3 2022.
- A 5-year average of $1.9 million and a median of $1.9 million in 2025 frame the typical range for Amortization of Deferred Charges.
- Annual changes were most pronounced in 2022 — Amortization of Deferred Charges retreated 10.34% — and 2023, when it grew 14.57%.
- Tracing KOD's Amortization of Deferred Charges over 5 years: stood at $1.7 million in 2022, then rose by 10.93% to $1.9 million in 2023, then gained by 6.09% to $2.1 million in 2024, then fell by 4.13% to $2.0 million in 2025, then advanced by 13.19% to $2.2 million in 2026.
- The last three Amortization of Deferred Charges figures came in at $2.2 million (Q1 2026), $2.0 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Kodiak Sciences | 2.21 Bn | 2.21 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | 1.90 Mn |
| Dec 31, 2021 | 1.90 Mn |
| Sep 30, 2021 | 1.91 Mn |
| Jun 30, 2021 | 1.94 Mn |
| Mar 31, 2021 | 1.96 Mn |
| Dec 31, 2020 | 1.94 Mn |
| Sep 30, 2020 | 1.59 Mn |
| Jun 30, 2020 | 101,000.00 |
| Mar 31, 2020 | 98,000.00 |
| Dec 31, 2019 | 97,000.00 |
| Sep 30, 2019 | 94,000.00 |
| Jun 30, 2019 | 92,000.00 |
| Mar 31, 2019 | 90,000.00 |
| Dec 31, 2018 | 187,000.00 |
| Sep 30, 2018 | 500,000.00 |
| Jun 30, 2018 | 1.87 Mn |
| Mar 31, 2018 | 1.46 Mn |
| Dec 31, 2017 | 769,000.00 |